Suppression of Hepatitis C Virus Replication is Maintained Long Term following Haart Therapy,in An Individual with HCV/HIV Co-Infection

Cooper C.L. , & Cameron D.W. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clinical Infectious Diseases 2002; 35: 873–879.

Rockstroh J.K. , Theisen A. , Kaiser R. , Sauerbruch T. , & Spengler U. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS 1998; 12: 829–830.

Perez-Olmeda M. , Rios P. , Nunez M. , Garcia-Samaniego J. , Romero M. , & Soriano V. Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment. AIDS 2002; 16: 493–495.

Fialaire P. , Payan C. , Vitour D. , Chennebault J.M. , Loison J. , Pichard E. , & Lunel F. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. Journal of Infectious Diseases 1999; 180: 574–575.

Yokozaki S. , Takamatsu J. , Nakano I. , Katano Y. , Toyoda H. , Hayashi K. , Hayakawa T. , & Fukuda Y. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of anti-retroviral therapy. Blood 2000; 96: 4293–4299.

Ranieri R. , Santambrogio C. , Veronelli A. , & Pontiroli A.E. Hepatitis C viremia persistently suppressed by HAART. Clinical Infectious Diseases 2003; 36: 1086–1087.

Lechner F. , Wong D.K. , Dunbar P.R. , Chapman R. , Chung R.T. , Dohrenwend P. , Robbins G. , Phillips R. , Klenerman P. , & Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. Journal of Experimental Medicine 2000; 191: 1499–1512.

Takaki A. , Wiese M. , Maertens G. , Depla E. , Seifert U. , Liebetrau A. , Miller J.L. , Manns M.P. , & Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nature Medicine 2000; 6: 578–582.

Harcourt G.C. , Lucas M. , Godkin A.J. , Kantzanou M. , Phillips R.E. , & Klenerman P. Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection. Clinical Experimental Immunology 2003; 131: 122–129.

Garcia-Samaniego J. , Bravo R. , Castilla J. , Gomez-Cano M. , Laguna F. , Munoz F. , & Soriano V. Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients. Journal of Hepatology 1998; 28: 526–527.

Zylberberg H. , Chaix M.L. , Rabian C. , Rouzioux C. , Aulong B. , Brechot C. , Viard J. P. , & Pol S. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects. Clinical Infectious Diseases 1998; 26: 1104–1106.